| Spirig HealthCare AG - Sapropterin Spirig HC 100 mg, Tabletten zur Herstellung einer Lösung zum Einnehmen |
| 69871 | | 01 | | Sapropterin Spirig HC 100 mg | | Tabletten zur Herstellung einer Lösung zum Einnehmen | | A16AX07 | | Sapropterin | | 18.10.2024 | | |
|
| Composition |
| sapropterini dihydrochloridum 100 mg corresp. sapropterinum 76.79 mg, mannitolum, crospovidonum, calcii hydrogenophosphas, E 300, E 101, natrii stearylis fumaras corresp. natrium 0.29 mg, pro compresso. |
| Packungsbestandteile |
| Tabletten zur Herstellung einer Lösung zum Einnehmen | | | | | Active Agent | Dose |
|---|
| Sapropterini Dihydrochloridum | 100 mg correspond Sapropterinum 76.79 mg |
| | BAG: Active Agent | Dose |
|---|
| Sapropterini Dihydrochloridum | 100 mg |
| | | | Inactive agents | | additional_information |
|---|
| Calcium Hydrogen Phosphate | | | | Crospovidonum | | | | E 101 | | color. | | E 300 | | | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Pro Compresso | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 851.18 | 940.80 | B | SL | No | | 002 | 120 | 2791.88 | 3052.75 | B | SL | No | | 003 | 30 | PR | PR | B | | No | | 004 | 120 | PR | PR | B | | No |
|
